Clinical trials
Amyloidosis trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Terminated | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 8 |
| Janssen Research & Development, LLC | 3 |
| Pfizer | 3 |
| Eidos Therapeutics, a BridgeBio company | 2 |
| Neurimmune AG | 2 |
| Proclara Biosciences, Inc. | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Bellus Health Inc. - a GSK company | 1 |
| C.T. Development America, Inc. | 1 |
| Intellia Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloidosis | 28 |
| Amyloid Neuropathies, Familial | 8 |
| Cardiomyopathies | 8 |
| Amyloidosis, Familial | 5 |
| Alzheimer Disease | 4 |
| Polyneuropathies | 3 |
| Amyloid Neuropathies | 2 |
| Heart Diseases | 2 |
| Recurrence | 2 |
| Arthritis, Rheumatoid | 1 |
Trials
Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.